Literature DB >> 15257658

The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activity.

Zoulika Kherrouche1, Yvan De Launoit, Didier Monte.   

Abstract

E2F6 is widely expressed in human tissues and cell lines. Recent studies have demonstrated its involvement in developmental patterning and in the regulation of various genes implicated in chromatin remodelling. Despite a growing number of studies, nothing is really known concerning the E2F6 expression regulation. To understand how cells control E2F6 expression, we analysed the activity of the previously cloned promoter region of the human E2F6 gene. DNase I footprinting, gel electrophoreticmobility shift, transient transfection and site-directed mutagenesis experiments allowed the identification of two functional NRF-1/alpha-PAL (nuclear respiratory factor-1/alpha-palindrome-binding protein)-binding sites within the human E2F6 core promoter region, which are conserved in the mouse and rat E2F6 promoter region. Moreover, ChIP (chromatin immunoprecipitation) analysis demonstrated that overexpressed NRF-1/alpha-PAL is associated in vivo with the E2F6 promoter. Furthermore, overexpression of full-length NRF-1/alpha-PAL enhanced E2F6 promoter activity, whereas expression of its dominant-negative form reduced the promoter activity. Our results indicate that NRF-1/alpha-PAL is implicated in the regulation of basal E2F6 gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257658      PMCID: PMC1133746          DOI: 10.1042/BJ20040935

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis.

Authors:  S Ishida; E Huang; H Zuzan; R Spang; G Leone; M West; J R Nevins
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Characterization of the 5'-flanking region of the rat gene for mitochondrial transcription factor A (Tfam).

Authors:  Yon Sik Choi; Hong Kyu Lee; Youngmi Kim Pak
Journal:  Biochim Biophys Acta       Date:  2002-03-19

Review 3.  Nuclear activators and coactivators in mammalian mitochondrial biogenesis.

Authors:  Richard C Scarpulla
Journal:  Biochim Biophys Acta       Date:  2002-06-07

4.  Characterization and identification of promoter elements in the mouse COX17 gene.

Authors:  Yoshinori Takahashi; Koichiro Kako; Hidenori Arai; Takahiro Ohishi; Yoshiko Inada; Akio Takehara; Akiyoshi Fukamizu; Eisuke Munekata
Journal:  Biochim Biophys Acta       Date:  2002-04-12

5.  A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.

Authors:  Hidesato Ogawa; Kei-Ichiro Ishiguro; Stefan Gaubatz; David M Livingston; Yoshihiro Nakatani
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

6.  Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells.

Authors:  Richard C Scarpulla
Journal:  Gene       Date:  2002-03-06       Impact factor: 3.688

7.  Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome.

Authors:  D Kumari; K Usdin
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

8.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

Authors:  Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

9.  Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6.

Authors:  Jörg Storre; Hans-Peter Elsässer; Miriam Fuchs; Diana Ullmann; David M Livingston; Stefan Gaubatz
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

10.  Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1.

Authors:  Alexandre Blais; Didier Monté; Frédéric Pouliot; Claude Labrie
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

View more
  7 in total

1.  The obligatory intestinal folate transporter PCFT (SLC46A1) is regulated by nuclear respiratory factor 1.

Authors:  Nitzan Gonen; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene.

Authors:  Zoulika Kherrouche; Alexandre Blais; Elisabeth Ferreira; Yvan De Launoit; Didier Monté
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

3.  Promoter regulation of the visinin-like subfamily of neuronal calcium sensor proteins by nuclear respiratory factor-1.

Authors:  Jian Fu; Jirong Zhang; Fang Jin; Jamie Patchefsky; Karl-Heinz Braunewell; Andres J Klein-Szanto
Journal:  J Biol Chem       Date:  2009-08-12       Impact factor: 5.157

Review 4.  Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.

Authors:  Kaumudi Bhawe; Deodutta Roy
Journal:  Cell Oncol (Dordr)       Date:  2018-07-25       Impact factor: 6.730

5.  Pathway Analysis of ChIP-Seq-Based NRF1 Target Genes Suggests a Logical Hypothesis of their Involvement in the Pathogenesis of Neurodegenerative Diseases.

Authors:  Jun-Ichi Satoh; Natsuki Kawana; Yoji Yamamoto
Journal:  Gene Regul Syst Bio       Date:  2013-11-04

6.  Silencing of Long Non-Coding RNA LINC00607 Prevents Tumor Proliferation of Osteosarcoma by Acting as a Sponge of miR-607 to Downregulate E2F6.

Authors:  Yuehuan Zheng; Zhe Chen; Zezhu Zhou; Xiangyang Xu; Huilin Yang
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

7.  Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation.

Authors:  Dan Wang; Baolan Wan; Xiaojing Zhang; Pingping Sun; Shu Lu; Chenxu Liu; Li Zhu
Journal:  BMC Gastroenterol       Date:  2022-04-21       Impact factor: 2.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.